Crossmark Global Holdings, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 3 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$200
-41.7%
7,817
-20.0%
0.01%
-28.6%
Q2 2023$343
+32.9%
9,777
-3.7%
0.01%
+16.7%
Q1 2023$258
-39.4%
10,152
-3.3%
0.01%
-45.5%
Q4 2022$426
-99.9%
10,501
-2.8%
0.01%
+10.0%
Q3 2022$357,000
-7.5%
10,808
-1.4%
0.01%0.0%
Q2 2022$386,000
-26.3%
10,962
-3.8%
0.01%
-16.7%
Q1 2022$524,000
-28.6%
11,392
+2.9%
0.01%
-25.0%
Q4 2021$734,000
+13.3%
11,072
+6.7%
0.02%
+6.7%
Q3 2021$648,000
-25.9%
10,372
-1.8%
0.02%
-28.6%
Q2 2021$875,000
+22.0%
10,560
-2.3%
0.02%
+16.7%
Q1 2021$717,000
-14.5%
10,810
-1.1%
0.02%
-14.3%
Q4 2020$839,000
+54.5%
10,930
-13.3%
0.02%
+40.0%
Q3 2020$543,0000.0%12,610
+0.3%
0.02%
-6.2%
Q2 2020$543,000
+56.0%
12,570
+3.8%
0.02%
+33.3%
Q1 2020$348,000
-55.0%
12,110
-0.7%
0.01%
-42.9%
Q4 2019$774,000
+87.9%
12,200
-16.6%
0.02%
+75.0%
Q3 2019$412,000
+6.5%
14,630
+0.2%
0.01%
+9.1%
Q2 2019$387,00014,6000.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders